Skip to main content
. 2014 Aug 25;4(2):31–34. doi: 10.1002/cld.376

Figure 1.

Figure 1

Individuals with active viral replications of hepatitis C have higher rates of all‐cause mortality compared with those with HCV exposure but no replication (anti‐HCV antibody positive, HCV‐RNA negative) and to those with neither antibody nor HCV RNA (A). However, viral eradication (eliminating HCV RNA through antiviral therapy) decreases this risk (B).1, 2